Inflammatory pseudotumor of the spleen in a patient with human immunodeficiency virus infection: a case report and review of the literature

Braun, B.; Cazorla, A.; Rivas, C.; Gárgolas, M.; Fernández-Guerrero, M.; Gárgolas, M; Fernández-Guerrero, M
August 2003
Annals of Hematology;Aug2003, Vol. 82 Issue 8, p511
Academic Journal
journal article
Inflammatory pseudotumor of the spleen (IPS) is a rarely described benign tumoral lesion of unknown etiology and pathogenesis. Diagnosis is complex as clinical manifestations and imaging features are indistinguishable from lymphoproliferative disorders and other malignancies of the spleen. Human immunodeficiency virus (HIV) infection is often combined with several malignancies including non-Hodgkin's lymphoma and Kaposi's sarcoma. However, no HIV infection-associated IPS has been reported so far. We report and discuss a case of IPS in an HIV-infected woman who presented with abdominal pain and multiple lesions in the spleen.


Related Articles

  • AIDS: Lessons from the last decade and prospects for the future. Sharma, Pramod K.; Tami, Thomas A. // ENT: Ear, Nose & Throat Journal;May95, Vol. 74 Issue 5, p329 

    Presents an overview of the impact of AIDS and HIV infections in the practice of medicine and otolaryngology. Evolution of the HIV pandemic; Modes of transmission; Medical management of HIV infections; Preventive measures.

  • HIV rounds at Cornell: Selected neurologic complications of HIV disease. Simpson, David // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p209 

    Examines the issue of neurological disorders during complications of human immunodeficiency virus (HIV) and acquired immunodeficiency virus (AIDS). How the central and peripheral nervous system could be affected; Identification of neurological disorders.

  • Metachronous Primary Carcinomas of the Lung in an HIV-Infected Patient. Aviram, Galit; Fishman, Joel E.; Schwartz, David S. // AIDS Patient Care & STDs;Jun2001, Vol. 15 Issue 6, p297 

    Studies have suggested that human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients have an increased risk of developing primary lung cancer, with a poor prognosis. We report a 59-year-old HIV-seropositive man who developed two metachronous primary bronchogenic...

  • Cavitary Lung Disease in AIDS: Etiologies and Correlation with Immune Status. Aviram, Galit; Fishman, Joel E.; Sagar, Meenor // AIDS Patient Care & STDs;Jul2001, Vol. 15 Issue 7, p353 

    To investigate the etiology and differential features of cavitary lung disease in patients with acquired immune deficiency syndrome (AIDS), chest computed tomography (CT) records from a 2-year period were reviewed to identify all human immunodeficiency virus (HIV)-positive patients with cavitary...

  • Common Neurologic Complications of HIV-1 Infection and AIDS. Newton, Herbert B. // American Family Physician;2/1/1995, Vol. 51 Issue 2, p387 

    Focuses on the common neurologic complications of HIV-1 infection and AIDS. Clinical presentation of the complications; Temporal profiles; Etiology of nervous system damage.

  • Longitudinal Analysis of Clinical Markers following Antiretroviral Therapy Initiated during Acute or Early HIV Type 1 Infection. Kassutto, Sigall; Maghsoudi, Kaveh; Johnston, Mary N.; Robbins, Gregory K.; Burgett, Nicole C.; Sax, Paul E.; Cohen, Daniel; Pae, Eunice; Davis, Ben; Zachary, Kimon; Basgoz, Nesli; D’agata, Erika M. C.; DeGruttola, Victor; Walker, Bruce D.; Rosenberg, Eric S. // Clinical Infectious Diseases;4/1/2006, Vol. 42 Issue 7, p1024 

    Background. Treatment of acute human immunodeficiency virus type 1 (HIV-1) infection may have unique immunologic, virological, and clinical benefits. However, the timing of treatment, optimal starting regimens, and expected response to therapy have not been defined. Methods. One hundred two...

  • Current Concepts in the Diagnosis and Management of Metabolic Complications of HIV Infection and Its Therapy. Wohl, David A.; McComsey, G.; Tebas, P.; Brown, T. T.; Glesby, M. J.; Reeds, D.; Shikuma, C.; Mulligan, K.; Dube, M.; Wininger, D.; Huang, J.; Revuelta, M.; Currier, J.; Swindells, S.; Fichtenbaum, C.; Basar, M.; Tungsiripat, M.; Meyer, W.; Weihe, J.; Wanke, C. // Clinical Infectious Diseases;9/1/2006, Vol. 43 Issue 5, p645 

    Changes in fat distribution, dyslipidemia, disordered glucose metabolism, and lactic acidosis have emerged as significant challenges to the treatment of human immunodeficiency virus (HIV) infection. Over the past decade, numerous investigations have been conducted to better define these...

  • An optimized method for high-titer lentivirus preparations without ultracentrifugation. Jiang, Wei; Hua, Rui; Wei, Mengping; Li, Chenhong; Qiu, Zilong; Yang, Xiaofei; Zhang, Chen // Scientific Reports;9/11/2015, p13875 

    Lentiviral technology has proven to be a powerful tool to express exogenous genes in dividing and non-dividing cells. Currently, most protocols for generating high-titer lentivirus require ultracentrifugation, which can be an instrumental barrier for routine operations in a laboratory. In this...

  • Human Immunodeficiency Virus-Associated Peripheral Neuropathies. Ferrari, Sergio; Vento, Sandro; Monaco, Salvatore; Cavallaro, Tiziana; Cainelli, Francesca; Rizzuto, Nicolo; Temesgen, Zelalem // Mayo Clinic Proceedings;Feb2006, Vol. 81 Issue 2, p213 

    Peripheral neuronathy has emerged as the most common neurologic complication of human immunodeficiency virus (HIV) infection. It will continue to play an important role in HIV infection given the fact that HIV-infected individuals are living longer, are at risk of long-term metabolic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics